Fingerpaint
Independent
Address
395 Broadway
Saratoga Springs, New York 12866
Web Address
Year Founded
2008
Full-time Employees
705
Number of Clients
45
North American Revenue 2021
Full-time Employees 2021
Number of clients 2021
Offices
North America
8
Locations
Saratoga Springs, NY
Conshohocken, PA
Cedar Knolls, NJ
Phoenix
Emeryville, CA
La Jolla, CA
Cary, NC
Charlotte, NC
Executives & Senior Management
Ed Mitzen
Chairman and CEO
Bill McEllen
Global President
Andy Pyfer
Partner
Senior Management
Bill McEllen
Global President
Ed Mitzen
Chairman and CEO
Andy Pyfer
Partner
Colleen Carter
Chief Marketing Officer
Jeralyn Mastroianni
Chief People Officer
Kevin Kish
Head of Finance
Jenny McKenna
Head of Operations
Rommel Fernandez
Chief Analytics Officer
Mark Willmann
Head of Fingerpaint Marketing
Roshawn Blunt
Managing Director, 1798
Brannon Cashion
Managing Partner, Leaderboard Branding
Scott Goudy
President, MedThink
Marry McGregor
Founder and Managing Partner, Engage
Agency 100 Book Cover
Capabilities/Services Offered
Professional
Consumer
OTC
Direct Marketing
Media Planning
Med-ed
Payer
Med-Tech
Public Health
Data/Analytics
Digital
New Services
Leaderboard Branding, a global naming and branding firm delivering strategic insights and world-class creativity to biopharma and healthcare companies as early as clinical phase one. With expertise in nonproprietary naming, clinical trial branding, trade name development, and visual design, Leaderboard Branding provides a strategic partnership through each phase of the drug development process.
MedThink, which offers extensive medical communications through two distinct divisions: MedThink SciCom, which harnesses deep scientific knowledge and extensive industry experience to develop solutions for medical affairs, medical communications and publication groups, and MedThink Communications, which provides healthcare communications and marketing services to commercial teams that leverages performance-driven medical education to enhance HCP beliefs and understanding.
Omnichannel
Acquisitions
2021 Acquisitions
3
Name
Leaderboard Branding
Splice
MedThink
Engage
Location
Charlotte, NC
Emeryville, CA
Cary, NC
Virginia
Specialty
allergy
anesthesiology
cardiology
dermatology
endocrinology
gastroenterology
hematology
immunology
infectious disease
mental health
metabolic diseases
nephrology
ophthalmology
orthopedics
oncology
otology
pain
pediatrics
podiatry
pulmonology
rare disease
radiology
rheumatology
sports medicine
vaccines
women's health
2021 U.S. Billings Breakdown
Sales Materials
8% - 100%
Consumer Digital/Web/Mobile
11% - 100%
Promotional Medical Education
6% - 100%
Market Research/Data/Analytics
10% - 100%
UX Design
5% - 100%
Professional Digital/Web/Mobile
15% - 100%
Consumer Print Ads
6% - 100%
Direct Marketing
2% - 100%
Mar-tech/Ad-tech
6% - 100%
Professional Print Ads
10% - 100%
Consumer Broadcast
10% - 100%
Payer Marketing
10% - 100%
Client Roster
Alexion
Almatica Pharma
Alnylam
American Regent
Amylyx
AngioDynamics
AstraZeneca
Avadel
Avion
Bausch & Lomb
Becton Dickinson
Biocodex
Biohaven
Blue Earth Diagnostic
BMS
Catalyst
Celgene/BMS
CSL Behring
Curium
Dendreon
Dynavax Technologies Corporation
Edwards Lifesciences
Endo
EPI
Fulcrum Therpeutics
Gilead
Global Blood Therapeutics
Grifols
Janssen
Neurelis
Otsuka Pharmaceutical
Passage Bio
Pear Therapeutics
Puma
Roche
Santen
Sarepta
Servier
SUN Pharma
Teva
Turning Point Therapeutics
Ultragenyx Pharmaceuticals
Zoetis
Zogenix
Growth
2021 Growth from Existing Clients
55%
2021 Growth from New Clients
30%
Trends and Challenges
Diversity and inclusion
Talent acquisition/retention
Payer-related challenges
Pricing-related issues
Getting an audience, virtually or otherwise, with HCPs
Healthcare Marketing Trends
More personalization of communications
Need to create more/better content/experiences
Heightened focus on payers
Increased concern over drug pricing
Industry consolidation
Scrutiny around social media
Impact of empowered patients/consumers
Intensified focus on analytics/ROI/measurement
Decreased impact of sales forces
Regulatory changes
Programs that go “beyond the pill”
Evolution of EHRs
Emphasis on specialty drugs/high-science categories
Adopting a data-science culture
More digital experimentation
Seizing opportunities around cannabis
Working from home
Ongoing fallout from pandemic
Creative Samples
